Breaking News Instant updates and real-time market news.

PLAN

Anaplan

$46.55 /

-10.43 (-18.30%)

09:47
05/27/21
05/27
09:47
05/27/21
09:47

Anaplan falls -18.4%

Anaplan is down -18.4%, or -$10.48 to $46.51.

  • 27

    May

  • 02

    Jun

  • 03

    Jun

PLAN Anaplan
$46.55 /

-10.43 (-18.30%)

05/14/21
Fly Intel: Top five analyst initiations
05/14/21 Goldman Sachs
Anaplan initiated with a Neutral at Goldman Sachs
05/10/21 Jefferies
Jefferies trims Anaplan price target to $85, sees 'beat and raise' coming
04/22/21 Wolfe Research
Anaplan initiated with an Outperform at Wolfe Research

TODAY'S FREE FLY STORIES

Earnings
Vonage reports Q2 adjusted EPS 5c, consensus 4c » 07:26
08/05/21
08/05
07:26
08/05/21
07:26
VG

Vonage

$14.27 /

-0.21 (-1.45%)

Reports Q2 revenue $351M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VG Vonage
$14.27 /

-0.21 (-1.45%)

VG Vonage
$14.27 /

-0.21 (-1.45%)

06/23/21 Citi
Vonage price target raised to $18 from $16 at Citi
06/21/21 Needham
Vonage initiated with a Hold at Needham
05/11/21 Craig-Hallum
8x8 downgraded to Hold at Craig-Hallum
03/05/21 Citi
Vonage price target raised to $16 from $15 at Citi
VG Vonage
$14.27 /

-0.21 (-1.45%)

VG Vonage
$14.27 /

-0.21 (-1.45%)

VG Vonage
$14.27 /

-0.21 (-1.45%)

VG Vonage
$14.27 /

-0.21 (-1.45%)

Downgrade
GoDaddy downgraded to Neutral from Buy at Rosenblatt » 07:26
08/05/21
08/05
07:26
08/05/21
07:26
GDDY

GoDaddy

$83.47 /

-0.55 (-0.65%)

Rosenblatt analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GDDY GoDaddy
$83.47 /

-0.55 (-0.65%)

GDDY GoDaddy
$83.47 /

-0.55 (-0.65%)

06:11 Today Piper Sandler
GoDaddy downgraded to Neutral from Overweight at Piper Sandler
07/19/21 Morgan Stanley
GoDaddy initiated with an Equal Weight at Morgan Stanley
07/13/21 Truist
GoDaddy expanded integration with Google a positive, says Truist
06/28/21 Barclays
GoDaddy price target raised to $115 from $107 at Barclays
GDDY GoDaddy
$83.47 /

-0.55 (-0.65%)

GDDY GoDaddy
$83.47 /

-0.55 (-0.65%)

Earnings
ChannelAdvisor sees Q3 revenue $41.3M-$41.7M, consensus $38.44M » 07:26
08/05/21
08/05
07:26
08/05/21
07:26
ECOM

ChannelAdvisor

$22.66 /

-0.6 (-2.58%)

Sees Q3 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ECOM ChannelAdvisor
$22.66 /

-0.6 (-2.58%)

ECOM ChannelAdvisor
$22.66 /

-0.6 (-2.58%)

02/12/21 B. Riley Securities
ChannelAdvisor price target raised to $36 from $30 at B. Riley Securities
02/09/21 B. Riley Securities
ChannelAdvisor price target raised to $30 from $24.50 at B. Riley Securities
11/05/20 Baird
ChannelAdvisor price target lowered to $18 from $20 at Baird
10/16/20
Fly Intel: Top five analyst upgrades
ECOM ChannelAdvisor
$22.66 /

-0.6 (-2.58%)

Earnings
Lee Enterprises reports Q3 EPS 55c vs. (23c) last year » 07:26
08/05/21
08/05
07:26
08/05/21
07:26
LEE

Lee Enterprises

$27.75 /

-2.25 (-7.50%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LEE Lee Enterprises
$27.75 /

-2.25 (-7.50%)

Earnings
Ironwood reports Q2 EPS 34c, consensus 22c » 07:26
08/05/21
08/05
07:26
08/05/21
07:26
IRWD

Ironwood

$12.92 /

-0.085 (-0.65%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IRWD Ironwood
$12.92 /

-0.085 (-0.65%)

IRWD Ironwood
$12.92 /

-0.085 (-0.65%)

02/09/21 Gordon Haskett
Ironwood odds of sale improved with CEO exit, says Gordon Haskett
11/06/20 Wells Fargo
Ironwood rally 'looks like a kneejerk overreaction,' says Wells Fargo
09/30/20
Fly Intel: Top five analyst downgrades
09/30/20 Wells Fargo
Ironwood downgraded to Equal Weight at Wells Fargo after pipeline miss
IRWD Ironwood
$12.92 /

-0.085 (-0.65%)

IRWD Ironwood
$12.92 /

-0.085 (-0.65%)

Earnings
TreeHouse reports Q2 adjusted EPS 26c, consensus 26c » 07:26
08/05/21
08/05
07:26
08/05/21
07:26
THS

TreeHouse

$42.15 /

-1.96 (-4.44%)

Reports Q2 revenue $1B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
THS TreeHouse
$42.15 /

-1.96 (-4.44%)

THS TreeHouse
$42.15 /

-1.96 (-4.44%)

02/12/21 Truist
TreeHouse downgraded to Hold from Buy at Truist
02/12/21 Truist
TreeHouse downgraded to Hold from Buy at Truist
02/12/21 BofA
TreeHouse downgraded to Neutral from Buy at BofA
02/12/21 BofA
TreeHouse downgraded to Neutral from Buy at BofA
THS TreeHouse
$42.15 /

-1.96 (-4.44%)

THS TreeHouse
$42.15 /

-1.96 (-4.44%)

THS TreeHouse
$42.15 /

-1.96 (-4.44%)

Recommendations
Cresco Labs price target lowered to $13.50 from $21.50 at Cantor Fitzgerald » 07:25
08/05/21
08/05
07:25
08/05/21
07:25
CRLBF

Cresco Labs

$10.88 /

-0.131798 (-1.20%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRLBF Cresco Labs
$10.88 /

-0.131798 (-1.20%)

CRLBF Cresco Labs
$10.88 /

-0.131798 (-1.20%)

07/07/21 Jefferies
Cresco Labs initiated with a Buy at Jefferies
03/29/21 Alliance Global Partners
NY cannabis bill 'big win' for Acreage and Curaleaf, says Alliance Global
03/26/21 Stifel
Cresco Labs price target lowered to C$34 from C$36 at Stifel
03/19/21 Stifel
Cresco Labs price target raised to C$36 from C$33.50 at Stifel
CRLBF Cresco Labs
$10.88 /

-0.131798 (-1.20%)

CRLBF Cresco Labs
$10.88 /

-0.131798 (-1.20%)

Earnings
Kontoor Brands raises FY21 adjusted EPS view to $3.90-$4.00 from $3.70-$3.80 » 07:25
08/05/21
08/05
07:25
08/05/21
07:25
KTB

Kontoor Brands

$57.97 /

+0.485 (+0.84%)

FY21 consensus $3.87.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KTB Kontoor Brands
$57.97 /

+0.485 (+0.84%)

KTB Kontoor Brands
$57.97 /

+0.485 (+0.84%)

07/14/21 Goldman Sachs
Kontoor Brands initiated with a Buy at Goldman Sachs
05/25/21 UBS
Kontoor Brands price target raised to $97 from $89 at UBS
05/07/21 Barclays
Kontoor Brands price target raised to $82 from $56 at Barclays
04/12/21 Piper Sandler
Kontoor Brands price target raised to $70 from $59 at Piper Sandler
KTB Kontoor Brands
$57.97 /

+0.485 (+0.84%)

KTB Kontoor Brands
$57.97 /

+0.485 (+0.84%)

Earnings
ChannelAdvisor reports Q2 EPS 15c, consensus 19c » 07:25
08/05/21
08/05
07:25
08/05/21
07:25
ECOM

ChannelAdvisor

$22.66 /

-0.6 (-2.58%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ECOM ChannelAdvisor
$22.66 /

-0.6 (-2.58%)

ECOM ChannelAdvisor
$22.66 /

-0.6 (-2.58%)

02/12/21 B. Riley Securities
ChannelAdvisor price target raised to $36 from $30 at B. Riley Securities
02/09/21 B. Riley Securities
ChannelAdvisor price target raised to $30 from $24.50 at B. Riley Securities
11/05/20 Baird
ChannelAdvisor price target lowered to $18 from $20 at Baird
10/16/20
Fly Intel: Top five analyst upgrades
ECOM ChannelAdvisor
$22.66 /

-0.6 (-2.58%)

Hot Stocks
Jounce Therapeutics expects cash to fund requirements through 3Q23 » 07:24
08/05/21
08/05
07:24
08/05/21
07:24
JNCE

Jounce Therapeutics

$5.13 /

-0.06 (-1.16%)

Based on its current…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNCE Jounce Therapeutics
$5.13 /

-0.06 (-1.16%)

JNCE Jounce Therapeutics
$5.13 /

-0.06 (-1.16%)

06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
06/15/21 Piper Sandler
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler
04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
03/14/21 Piper Sandler
Jounce Therapeutics initiated with an Overweight at Piper Sandler
JNCE Jounce Therapeutics
$5.13 /

-0.06 (-1.16%)

  • 10
    Mar
JNCE Jounce Therapeutics
$5.13 /

-0.06 (-1.16%)

Recommendations
Tivity Health price target lowered to $33 from $36 at Cantor Fitzgerald » 07:24
08/05/21
08/05
07:24
08/05/21
07:24
TVTY

Tivity Health

$25.38 /

-0.26 (-1.01%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TVTY Tivity Health
$25.38 /

-0.26 (-1.01%)

TVTY Tivity Health
$25.38 /

-0.26 (-1.01%)

06:54 Today Piper Sandler
Tivity Health price target lowered to $25 from $27 at Piper Sandler
06/09/21 Cantor Fitzgerald
Tivity Health price target raised to $36 from $32 at Cantor Fitzgerald
02/25/21 Barrington
Tivity Health price target raised to $32 from $28 at Barrington
02/25/21 Piper Sandler
Tivity Health price target raised to $27 from $16 at Piper Sandler
TVTY Tivity Health
$25.38 /

-0.26 (-1.01%)

Downgrade
William Blair downgrades Fastly on 'uncertainty and unpredictability' » 07:24
08/05/21
08/05
07:24
08/05/21
07:24
FSLY

Fastly

$44.50 /

-1.7 (-3.68%)

William Blair analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FSLY Fastly
$44.50 /

-1.7 (-3.68%)

FSLY Fastly
$44.50 /

-1.7 (-3.68%)

06:41 Today Citi
Fastly price target lowered to $33 from $46 at Citi
06:09 Today Piper Sandler
Fastly price target lowered to $32 from $45 at Piper Sandler
04:40 Today William Blair
Fastly downgraded to Market Perform from Outperform at William Blair
06/10/21 RBC Capital
Fastly initiated with a Sector Perform at RBC Capital
FSLY Fastly
$44.50 /

-1.7 (-3.68%)

FSLY Fastly
$44.50 /

-1.7 (-3.68%)

FSLY Fastly
$44.50 /

-1.7 (-3.68%)

FSLY Fastly
$44.50 /

-1.7 (-3.68%)

Earnings
Cardinal Health sees FY22 EPS $5.60-$5.90, consensus $6.19 » 07:24
08/05/21
08/05
07:24
08/05/21
07:24
CAH

Cardinal Health

$59.01 /

-0.6 (-1.01%)

Sees FY22 capital…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CAH Cardinal Health
$59.01 /

-0.6 (-1.01%)

CAH Cardinal Health
$59.01 /

-0.6 (-1.01%)

07/20/21 Jefferies
Report of $21B opioid settlement positive for drug distributors, says Jefferies
06/07/21 Jefferies
Approval of Biogen Alzheimer's drug could be catalyst for RadNet, says Jefferies
05/10/21
Fly Intel: Top five analyst downgrades
05/10/21 Baird
Cardinal Health downgraded to Neutral from Outperform at Baird
CAH Cardinal Health
$59.01 /

-0.6 (-1.01%)

CAH Cardinal Health
$59.01 /

-0.6 (-1.01%)

CAH Cardinal Health
$59.01 /

-0.6 (-1.01%)

CAH Cardinal Health
$59.01 /

-0.6 (-1.01%)

Recommendations
Rapid7 price target raised to $138 from $120 at RBC Capital » 07:24
08/05/21
08/05
07:24
08/05/21
07:24
RPD

Rapid7

$116.34 /

+0.92 (+0.80%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPD Rapid7
$116.34 /

+0.92 (+0.80%)

RPD Rapid7
$116.34 /

+0.92 (+0.80%)

07:06 Today Baird
Rapid7 price target raised to $130 from $95 at Baird
07:01 Today Barclays
Rapid7 price target raised to $130 from $115 at Barclays
06:51 Today Mizuho
Rapid7 price target raised to $125 from $110 at Mizuho
08/02/21
Fly Intel: Top five analyst initiations
RPD Rapid7
$116.34 /

+0.92 (+0.80%)

RPD Rapid7
$116.34 /

+0.92 (+0.80%)

Earnings
Jounce Therapeutics reports Q2 EPS (8c), consensus (36c) » 07:24
08/05/21
08/05
07:24
08/05/21
07:24
JNCE

Jounce Therapeutics

$5.13 /

-0.06 (-1.16%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JNCE Jounce Therapeutics
$5.13 /

-0.06 (-1.16%)

JNCE Jounce Therapeutics
$5.13 /

-0.06 (-1.16%)

06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
06/15/21 Piper Sandler
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler
04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
03/14/21 Piper Sandler
Jounce Therapeutics initiated with an Overweight at Piper Sandler
JNCE Jounce Therapeutics
$5.13 /

-0.06 (-1.16%)

  • 10
    Mar
JNCE Jounce Therapeutics
$5.13 /

-0.06 (-1.16%)

Earnings
Berry Global back pior FY 21 organic volume growth of +5% » 07:24
08/05/21
08/05
07:24
08/05/21
07:24
BERY

Berry Global

$63.74 /

-1.49 (-2.28%)

"Given our continued…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BERY Berry Global
$63.74 /

-1.49 (-2.28%)

BERY Berry Global
$63.74 /

-1.49 (-2.28%)

05/21/21 BMO Capital
Berry Global price target raised to $82 from $78 at BMO Capital
05/05/21 Wells Fargo
Berry Global price target raised to $80 from $72 at Wells Fargo
05/05/21 Deutsche Bank
Berry Global price target raised to $78 from $70 at Deutsche Bank
04/15/21 Jefferies
Berry Global price target raised to $73 from $70 at Jefferies
BERY Berry Global
$63.74 /

-1.49 (-2.28%)

BERY Berry Global
$63.74 /

-1.49 (-2.28%)

Earnings
CareCloud raises FY21 revenue view $135M-$138M from $133M-$137M, consensus $135M » 07:24
08/05/21
08/05
07:24
08/05/21
07:24
MTBC

CareCloud

$8.65 /

+0.16 (+1.88%)

Sees FY21 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MTBC CareCloud
$8.65 /

+0.16 (+1.88%)

MTBC CareCloud
$8.65 /

+0.16 (+1.88%)

06/11/21 Cantor Fitzgerald
CareCloud initiated with an Overweight at Cantor Fitzgerald
02/25/21 Roth Capital
MTBC's efforts to increase organic growth working, says Roth Capital
01/28/21
Fly Intel: Top five analyst initiations
01/28/21 Maxim
MTBC initiated with a Buy at Maxim
MTBC CareCloud
$8.65 /

+0.16 (+1.88%)

Hot Stocks
Kontoor Brands board authorizes $200M share repurchase program  07:23
08/05/21
08/05
07:23
08/05/21
07:23
KTB

Kontoor Brands

$57.97 /

+0.485 (+0.84%)

 
ShowHide Related Items >><<
KTB Kontoor Brands
$57.97 /

+0.485 (+0.84%)

KTB Kontoor Brands
$57.97 /

+0.485 (+0.84%)

07/14/21 Goldman Sachs
Kontoor Brands initiated with a Buy at Goldman Sachs
05/25/21 UBS
Kontoor Brands price target raised to $97 from $89 at UBS
05/07/21 Barclays
Kontoor Brands price target raised to $82 from $56 at Barclays
04/12/21 Piper Sandler
Kontoor Brands price target raised to $70 from $59 at Piper Sandler
KTB Kontoor Brands
$57.97 /

+0.485 (+0.84%)

KTB Kontoor Brands
$57.97 /

+0.485 (+0.84%)

Earnings
TCR2 Therapeutics reports Q2 EPS (64c), consensus (59c) » 07:23
08/05/21
08/05
07:23
08/05/21
07:23
TCRR

TCR2 Therapeutics

$12.79 /

-0.26 (-1.99%)

TCR2 ended Q2 with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TCRR TCR2 Therapeutics
$12.79 /

-0.26 (-1.99%)

TCRR TCR2 Therapeutics
$12.79 /

-0.26 (-1.99%)

06/24/21 Goldman Sachs
TCR2 Therapeutics initiated with a Buy at Goldman Sachs
06/11/21 BMO Capital
TCR2 Therapeutics coverage transferred at BMO Capital
05/14/21 Wedbush
TCR2 Therapeutics price target lowered to $45 from $57 at Wedbush
03/12/21 Mizuho
TCR2 Therapeutics price target lowered to $51 from $58 at Mizuho
TCRR TCR2 Therapeutics
$12.79 /

-0.26 (-1.99%)

  • 20
    Jan
Earnings
Kontoor Brands reports Q2 adjusted EPS 70c, consensus 35c » 07:23
08/05/21
08/05
07:23
08/05/21
07:23
KTB

Kontoor Brands

$57.97 /

+0.485 (+0.84%)

Reports Q2 revenue $491M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KTB Kontoor Brands
$57.97 /

+0.485 (+0.84%)

KTB Kontoor Brands
$57.97 /

+0.485 (+0.84%)

07/14/21 Goldman Sachs
Kontoor Brands initiated with a Buy at Goldman Sachs
05/25/21 UBS
Kontoor Brands price target raised to $97 from $89 at UBS
05/07/21 Barclays
Kontoor Brands price target raised to $82 from $56 at Barclays
04/12/21 Piper Sandler
Kontoor Brands price target raised to $70 from $59 at Piper Sandler
KTB Kontoor Brands
$57.97 /

+0.485 (+0.84%)

KTB Kontoor Brands
$57.97 /

+0.485 (+0.84%)

Hot Stocks
Kala Pharmaceuticals sees cash funding operations for at least two years » 07:22
08/05/21
08/05
07:22
08/05/21
07:22
KALA

Kala Pharmaceuticals

$3.36 /

-0.08 (-2.33%)

As of June 30, 2021, Kala…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KALA Kala Pharmaceuticals
$3.36 /

-0.08 (-2.33%)

KALA Kala Pharmaceuticals
$3.36 /

-0.08 (-2.33%)

05/06/21 H.C. Wainwright
Kala Pharmaceuticals price target lowered to $14 from $16 at H.C. Wainwright
04/29/21
Kala Pharmaceuticals participates in a conference call hosted by Northland
04/29/21
Kala Pharmaceuticals participates in a conference call hosted by Northland
04/09/21 JPMorgan
Kala Pharmaceuticals risk/reward 'highly favorable,' says JPMorgan
KALA Kala Pharmaceuticals
$3.36 /

-0.08 (-2.33%)

KALA Kala Pharmaceuticals
$3.36 /

-0.08 (-2.33%)

Recommendations
Acadia Pharmaceuticals price target lowered to $27 from $33 at Cantor Fitzgerald » 07:22
08/05/21
08/05
07:22
08/05/21
07:22
ACAD

Acadia Pharmaceuticals

$21.05 /

-0.53 (-2.46%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACAD Acadia Pharmaceuticals
$21.05 /

-0.53 (-2.46%)

ACAD Acadia Pharmaceuticals
$21.05 /

-0.53 (-2.46%)

06/10/21 Berenberg
Berenberg starts Acadia Pharmaceuticals at Hold amid DRP uncertainty
06/10/21 Berenberg
Acadia Pharmaceuticals initiated with a Hold at Berenberg
04/07/21 Needham
Acadia price target lowered to $30 from $44 at Needham
04/07/21 H.C. Wainwright
Acadia downgraded to Neutral from Buy at H.C. Wainwright
ACAD Acadia Pharmaceuticals
$21.05 /

-0.53 (-2.46%)

ACAD Acadia Pharmaceuticals
$21.05 /

-0.53 (-2.46%)

Earnings
Cardinal Health reports Q4 EPS 77c, consensus $1.20 » 07:22
08/05/21
08/05
07:22
08/05/21
07:22
CAH

Cardinal Health

$59.01 /

-0.6 (-1.01%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CAH Cardinal Health
$59.01 /

-0.6 (-1.01%)

CAH Cardinal Health
$59.01 /

-0.6 (-1.01%)

07/20/21 Jefferies
Report of $21B opioid settlement positive for drug distributors, says Jefferies
06/07/21 Jefferies
Approval of Biogen Alzheimer's drug could be catalyst for RadNet, says Jefferies
05/10/21
Fly Intel: Top five analyst downgrades
05/10/21 Baird
Cardinal Health downgraded to Neutral from Outperform at Baird
CAH Cardinal Health
$59.01 /

-0.6 (-1.01%)

CAH Cardinal Health
$59.01 /

-0.6 (-1.01%)

CAH Cardinal Health
$59.01 /

-0.6 (-1.01%)

CAH Cardinal Health
$59.01 /

-0.6 (-1.01%)

Earnings
CareCloud reports Q2 adjusted EPS 26c, consensus (28c) » 07:22
08/05/21
08/05
07:22
08/05/21
07:22
MTBC

CareCloud

$8.65 /

+0.16 (+1.88%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MTBC CareCloud
$8.65 /

+0.16 (+1.88%)

MTBC CareCloud
$8.65 /

+0.16 (+1.88%)

06/11/21 Cantor Fitzgerald
CareCloud initiated with an Overweight at Cantor Fitzgerald
02/25/21 Roth Capital
MTBC's efforts to increase organic growth working, says Roth Capital
01/28/21
Fly Intel: Top five analyst initiations
01/28/21 Maxim
MTBC initiated with a Buy at Maxim
MTBC CareCloud
$8.65 /

+0.16 (+1.88%)

Downgrade
Nevro downgraded to Market Perform on uncertainty at William Blair » 07:22
08/05/21
08/05
07:22
08/05/21
07:22
NVRO

Nevro

$147.83 /

-3.47 (-2.29%)

William Blair analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVRO Nevro
$147.83 /

-3.47 (-2.29%)

NVRO Nevro
$147.83 /

-3.47 (-2.29%)

06:49 Today Canaccord
Nevro downgraded to Hold from Buy at Canaccord
06:10 Today JMP Securities
Nevro price target lowered to $160 from $190 at JMP Securities
06:06 Today Piper Sandler
Nevro downgraded to Neutral from Overweight at Piper Sandler
06:00 Today Citi
Nevro downgraded to Neutral from Buy at Citi
NVRO Nevro
$147.83 /

-3.47 (-2.29%)

NVRO Nevro
$147.83 /

-3.47 (-2.29%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.